Buy or sell Mindstrong Health stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Mindstrong Health Stock

Mindstrong Health is transforming the diagnosis and treatment of behavioral health disorders through the ubiquity of mobile technology



Notable Investors

ARCH Venture Partners


Palo Alto CA, US

Total Funding


About Mindstrong Health Stock

Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.


Funding History

June 2017$14.0M


Co-Founder and Executive Chairman

Richard Klausner

Founder and CEO

Paul Dagum

Co-Founder and President

Thomas Insel


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mindstrong Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: